Wei Teng

6PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 30, 2025
The impact of single-nucleotide variants of hepatitis B virus and antiviral on liver cancer in gray zone patients.

Wei Teng, Ting-Tsung Chang, Chien-Wei Su

|Dec 05, 2022
Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first-line treatment for unresectable hepatocellular carcinoma.

Chung-Wei Su, Wei Teng, Po-Ting Lin

|Apr 18, 2022
Soluble form of CTLA-4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients.

Wei Teng, Wen-Juei Jeng, Wei-Ting Chen

|Oct 29, 2020
Efficacy and Adverse Effects of Self-Expandable Metal Stent Placement for Malignant Duodenal Obstruction: The Papilla of Vater as a Landmark.

Chi-Huan Wu, Mu-Hsien Lee, Yung-Kuan Tsou

|Jun 24, 2017
Eradication of hepatitis C virus profoundly prolongs survival in hepatocellular carcinoma patients receiving transarterial chemoembolization.

W Teng, Y-C Hsieh, K-W Lui

Pageof 1

Frequent Collaborators

2 joint publications

Wen-Juei Jeng

2 joint publications

Chun-Yen Lin

1 joint publications

Y-C Chen

1 joint publications

Chi-Huan Wu